Please login to the form below

Not currently logged in
Email:
Password:

AZ files Crestor patent lawsuits in US

AstraZeneca files patent infringement lawsuits against seven pharmaceutical companies that are attempting to market generic versions of its cholesterol-lowering blockbuster Crestor

UK-based pharmaceutical company, AstraZeneca (AZ), has filed patent infringement lawsuits against seven pharmaceutical companies that are attempting to market generic versions of its cholesterol blockbuster Crestor (rosuvastatin).

The lawsuits were filed in US District Court against the US-based companies Cobalt, Aurobindo Pharma, Par Pharmaceutical, Mylan Pharmaceuticals and Sun Pharmaceutical. Canada's Apotex and Germany's Sandoz International are also involved.

Crestor is AZ's third-best-selling treatment, with FY06 sales of USD 2bn. Shares in the company dropped in value by 0.9 per cent to reach GBP 22.77 (USD 46.58) in midday trading on 12 December 2007 in London.

12th December 2007

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
M&F Health

M&F Health is a full service communications agency, dedicated to the health and wellbeing sector. We are an independent amongst...

Latest intelligence

Beyond the event
...
Anthill Agency and Actando partnership to Transform Pharma's Digital Skills
Anthill Agency, a leading life sciences digital agency, today announced the launch of the Anthill Academy™ and partnership with Actando's PharmAcademy....
Is the pharma business model ready for precision medicine?
Precision medicine promises to revolutionise patient outcomes and reduce costs for industry but is pharma ready for it? Blue Latitude Health co-founder Head of Strategy Fred Bassett explores the challenges...

Infographics